On March 15, 2023, Johnson & Johnson announced that it has received a shareholder proposal from Mercy Investment Services Inc, asking the Company to establish and report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents. In addition, the Company recommended the shareholders to vote against the proposal at the annual meeting of shareholders scheduled to be held on April 27, 2023.